IMMU-25. RADIO-IMMUNOTHERAPY USING THE IDO PATHWAY INHIBITOR INDOXIMOD FOR CHILDREN WITH NEWLY-DIAGNOSED DIPG

BACKGROUND: Indoximod is an IDO pathway inhibitor with a differentiated mechanism of action directly targeting immune cells to reverse the immune suppression generated by tumors. An ongoing phase-1b/2a study (NCT02502708) using indoximod in combination with temozolomide and/or re-irradiation for chi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Johnson, Theodore S, Aguilera, Dolly, Al-Basheer, Ahmad, Castellino, Craig, Eaton, Bree R, Esiashvili, Natia, Foreman, Nicholas, Heger, Ian M, Kennedy, Eugene P, Link, Charles J, Martin, William, Ring, Eric, Sadek, Ramses F, Smith, Amy, Vahanian, Nicholas N, MacDonald, Tobey J, Munn, David H
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012944/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.341
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados